- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
This Editor's Choice piece discusses the ramifications of not reaching a deal on the looming fiscal cliff.
Start doing your homework on the banking story now, while things look bleak
Banks will likely seem un-investible near-term amid the political consequences of this mess.